Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.
Chen Y, Dai X, Chen W, Qiao Y, Bai R, Duan X, Zhang K, Chen X, Li X, Mo S, Cao W, Li X, Liu K, Dong Z, Lu J.
Chen Y, et al. Among authors: li x.
Oncogene. 2023 Jul;42(29):2278-2293. doi: 10.1038/s41388-023-02750-2. Epub 2023 Jun 22.
Oncogene. 2023.
PMID: 37349644